Capstone Triton Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
+8,217
New +$1.77M 1.19% 22
2026
Q1
Sell
-8,641
Closed -$1.97M 64
2025
Q4
$1.97M Buy
8,641
+156
+2% +$35.5K 1.31% 20
2025
Q3
$1.96M Buy
8,485
+161
+2% +$32.8K 1.32% 22
2025
Q2
$1.55M Buy
+8,324
New +$1.55M 1.12% 31
2024
Q4
$1.4M Buy
7,889
+4
+0.1% +$735 0.88% 39
2024
Q3
$1.56M Sell
7,885
-199
-2% -$37.1K 1% 33
2024
Q2
$1.39M Sell
8,084
-55
-0.7% -$9.11K 0.97% 33
2024
Q1
$1.48M Buy
8,139
+152
+2% +$26.2K 1.05% 33
2023
Q4
$1.24M Sell
7,987
-718
-8% -$105K 0.9% 37
2023
Q3
$1.3M Buy
8,705
+104
+1% +$15.3K 0.95% 37
2023
Q2
$1.16M Buy
8,601
+223
+3% +$32.7K 0.8% 46
2023
Q1
$1.34M Buy
8,378
+489
+6% +$74.8K 1% 36
2022
Q4
$1.27M Buy
7,889
+627
+9% +$96.1K 1.02% 35
2022
Q3
$975K Buy
7,262
+205
+3% +$29.4K 0.83% 43
2022
Q2
$1.04M Buy
7,057
+277
+4% +$42.3K 0.79% 44
2022
Q1
$1.07M Buy
6,780
+475
+8% +$69K 0.75% 41
2021
Q4
$857K Buy
6,305
+623
+11% +$73.6K 1.73% 14
2021
Q3
$617K Buy
5,682
+969
+21% +$111K 0.37% 67
2021
Q2
$531K Buy
4,713
+610
+15% +$68.7K 0.33% 67
2021
Q1
$444K Buy
4,103
+128
+3% +$13.7K 0.29% 66
2020
Q4
$426K Buy
+3,975
New +$382K 0.26% 60

Other funds holding ABBV

Capstone Triton Financial Group's ABBV Position: Q2 2026 in Review

Capstone Triton Financial Group opened a new position in AbbVie (ABBV) in Q2 2026: 8,217 shares worth $2.07M. The stake represents 1.19% of the portfolio and ranks #22 among its holdings. This is a return to the name: Capstone Triton Financial Group previously reported a position in ABBV as recently as Q4 2025.

Capstone Triton Financial Group first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Capstone Triton Financial Group held 8,217 shares of AbbVie worth $2.07M as of Q2 2026.
  • AbbVie was a new Capstone Triton Financial Group position in Q2 2026.
  • AbbVie made up 1.19% of Capstone Triton Financial Group's portfolio in Q2 2026, its #22 holding.
  • Capstone Triton Financial Group first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capstone Triton Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.